Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pre-exposure Prophylaxis for Prevention of HIV Infection”

108 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 108 results

Not applicableStudy completedNCT03565575
What this trial is testing

Manicaland PrEP Uptake Through Interactive Counselling Trial

Who this might be right for
Improving Perceptions of HIV RiskImproving Uptake of Pre-exposure Prophylaxis for HIV
Simon Gregson 1,055
Not applicableLooking for participantsNCT06056544
What this trial is testing

Client-Centered Care Coordination for Black Men Who Have Sex With Men

Who this might be right for
HIV PreventionHIV Pre-exposure Prophylaxis
University of Maryland, Baltimore 350
Large-scale testing (Phase 3)Study completedNCT04937881
What this trial is testing

PK of TAF and TDF for PrEP in Pregnant and Postpartum Women

Who this might be right for
Hiv
University of California, Los Angeles 39
Testing effectiveness (Phase 2)Study completedNCT02213328
What this trial is testing

Acceptability, Safety, and Use of Daily Truvada Pre-Exposure Prophylaxis in Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 148
Not applicableLooking for participantsNCT06807736
What this trial is testing

PrEPared to Choose (PtC) is an Implementation Study of the Delivery of Cabotegravir Long-acting, an Injectable Pre-exposure Prophylaxis (PrEP) Option for HIV Prevention. Injectable PrEP Will be Offered Alongside Oral and Vaginal Ring PrEP From Within a Real-world Context in Cape Town, South Africa.

Who this might be right for
HIV InfectionSexual and Reproductive Health
Desmond Tutu HIV Foundation 1,800
Post-approval studies (Phase 4)Study completedNCT04050540
What this trial is testing

Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP

Who this might be right for
HIV InfectionsHIV/AIDSNeisseria Gonorrheae Infection+2 more
University of Washington 449
Testing effectiveness (Phase 2)Active Not RecruitingNCT06101342
What this trial is testing

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)

Who this might be right for
Pre-Exposure Prophylaxis of HIV Infection
Gilead Sciences 181
Large-scale testing (Phase 3)Not Yet RecruitingNCT06273943
What this trial is testing

Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.

Who this might be right for
Prevention
ANRS, Emerging Infectious Diseases 322
Not applicableStudy completedNCT01865799
What this trial is testing

A Prospective, Observational, Drug Utilization Study of Subjects Taking Truvada for Pre-exposure Prophylaxis in the USA

Who this might be right for
Pre-exposure Prophylaxis for Prevention of HIV Infection
Gilead Sciences 64,186
Large-scale testing (Phase 3)Looking for participantsNCT07047716
What this trial is testing

Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)

Who this might be right for
HIV Pre-exposure Prophylaxis
Gilead Sciences 350
Not applicableEnded earlyNCT03449771
What this trial is testing

PrEP and Consumptions

Who this might be right for
Psychoactive Substance UseMood Disorders
University Hospital, Montpellier 237
Not applicableUnknownNCT04044235
What this trial is testing

Evaluation of Pre-Exposure Prophylaxis for High Risk Adolescent Girls and Young Women

Who this might be right for
HIV/AIDS
Lighthouse Trust 1,032
Post-approval studies (Phase 4)Study completedNCT03642704
What this trial is testing

HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure

Who this might be right for
Mother to Child HIV Transmission
ANRS, Emerging Infectious Diseases 56
Large-scale testing (Phase 3)Looking for participantsNCT06134362
What this trial is testing

Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

Who this might be right for
HIV Infections
ViiV Healthcare 3,508
Not applicableStudy completedNCT03805451
What this trial is testing

Life Steps for PrEP for Youth

Who this might be right for
HIVPre-exposure ProphylaxisMedication Adherence
Fenway Community Health 32
Post-approval studies (Phase 4)Study completedNCT02237027
What this trial is testing

Early Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention Among Female Sex Workers in Cotonou, Benin

Who this might be right for
Adherence to Medication Regime
CHU de Quebec-Universite Laval 361
Not applicableEnrolling By InvitationNCT02437981
What this trial is testing

Evaluation of PrEP-30: a Demonstration Project of Pre-exposure Prophylaxis for MSM and Other High-risk Group Clients at the Thai Red Cross Anonymous Clinic

Who this might be right for
HIV Prevention
Thai Red Cross AIDS Research Centre 20,000
Not applicableStudy completedNCT04269434
What this trial is testing

GonoScreen: Efficacy of Screening STIs in MSM

Who this might be right for
Neisseria Gonorrhoeae InfectionChlamydia Trachomatis Infection
Institute of Tropical Medicine, Belgium 1,014
Not applicableStudy completedNCT05465265
What this trial is testing

PrEP for Prevention of HIV Transmission Among People Who Inject Drugs in Nairobi, Kenya

Who this might be right for
HIV Antibody PositivityPrEP Uptake
University of Washington 256
Not applicableStudy completedNCT01751659
What this trial is testing

Clinician Attitudes and Behaviors Regarding Use of Pre-Exposure Prophylaxis (PrEP) for Primary HIV Prevention

Who this might be right for
Clinician Attitudes About PrEP
University of North Carolina, Chapel Hill 62
Load More Results